Provided by Tiger Trade Technology Pte. Ltd.

Adaptimmune Therapeutics PLC

0.0549
0.0000
Volume:- -
Turnover:- -
Market Cap:14.55M
PE:-0.08
High:0.0549
Open:0.0549
Low:0.0549
Close:0.0549
52wk High:0.8100
52wk Low:0.0403
Shares:265.05M
Float Shares:183.08M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6574
EPS(LYR):-0.2807
ROE:-1341.10%
ROA:-40.86%
PB:-0.21
PE(LYR):-0.20

Loading ...

Feb 07, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Jan 22, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Jan 14, 2020

Major Issues Report

Current report, items 1.01, 7.01, 8.01, and 9.01
Jan 13, 2020

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Jan 13, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Nov 26, 2019

Major Issues Report

Current report, item 1.01
Nov 06, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 06, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 01, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Sep 30, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 06, 2019

Correspondence

[Cover]Correspondence
Aug 30, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 27, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Aug 07, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 05, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Aug 05, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Aug 01, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 01, 2019

Major Issues Report

Current report, items 5.02, 8.01, and 9.01
Aug 01, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jul 25, 2019

Major Issues Report

Current report, items 8.01 and 9.01